About
About ClinicalInvestor
Making clinical-stage biotech investing accessible to everyone, not just Wall Street insiders.
Our Mission
Biotech stocks move on clinical data, FDA decisions, and scientific catalysts that most investors find impossible to track. ClinicalInvestor exists to change that.
We aggregate, structure, and explain the events that drive biotech stock prices so you can make informed decisions without a PhD in pharmacology.
What We Provide
Catalyst Calendar
FDA decision dates from company filings, and monthly calendars that show a day only when a primary source states it.
Company Profiles
Cash, burn and runway from SEC filings, pipelines checked against ClinicalTrials.gov, and the sponsor’s late-stage trial record.
Educational Guides
Step-by-step guides on reading clinical trial data, understanding FDA processes, and evaluating biotech stocks.
Trial Translator
Our free tool that pulls live ClinicalTrials.gov data and applies a rules-based investor checklist to break down trial results in plain English.
Our Data Sources
Accuracy matters when money is on the line. Figures and dates link to the record they come from:
SEC: 8-K filings stating PDUFA dates and outcomes; XBRL figures from 10-Q and 10-K filings
FDA: Drugs@FDA approvals; advisory committee notices in the Federal Register
ClinicalTrials.gov: Trial records, status, primary-completion dates, sponsor trial histories, competing studies
Exactly which field comes from which source, and how often it refreshes, is on the editorial standards page.
Who is behind this site
Publisher: Blane Jackson, DDS, MBA. Responsible for what the site publishes, its sourcing rules and its corrections.
Scientific and financial review: none at present. No page has been checked by a pharmacologist, physician or securities analyst unless its byline says “Reviewed by” and names the reviewer and the date. Every other page says it is AI-drafted and not individually reviewed. If a reviewer joins, they will be named here with their credentials.
That is why the structured facts carry their sources: you can check a PDUFA date against the filing that states it, or a cash figure against the 10-Q it comes from, without taking our word for it.
Frequently asked questions
- What is ClinicalInvestor?
- ClinicalInvestor is a free educational site for retail biotech investors. It publishes an FDA decision calendar built from company filings, company pages that lead with figures from SEC filings, trial pages built on ClinicalTrials.gov records, and guides. Explanatory text is AI-drafted and labelled as such.
- Is ClinicalInvestor free to use?
- Yes. All core tools — the catalyst calendar, company profiles, Trial Translator, and educational guides — are free and require no signup.
- Where does ClinicalInvestor get its data?
- PDUFA dates come from the sponsor’s own 8-K filings, outcomes from Drugs@FDA, advisory committee meetings from FDA notices in the Federal Register, cash and burn from SEC XBRL filings, and trial records from ClinicalTrials.gov. The FDA does not publish pending decision dates itself. Field-by-field detail is on our editorial standards page.
Important Disclaimer
ClinicalInvestor is an educational resource, not a financial advisor. Nothing on this site constitutes personalized investment advice. Biotech investing carries substantial risk. Always do your own due diligence and consider consulting a licensed financial professional before making investment decisions.
See also our editorial policy and disclosures.
Get In Touch
Have feedback, a correction, or a suggestion? We want to hear from you. Reach us at hello@clinicalinvestor.com.